glutathione rapta c The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials Anticancer activity of RAPTA-EA1 in
Anticancer activity of RAPTA EA1 in triple negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib ScienceDirect Combinative Treatment of the PARP Inhibitor Olaparib and Antimetastasis Ruthenium(II)Arene Compound RAPTA T for Triple Negative BRCA1 Wild Type Breast Cancer Cells Frontiers Applications of Ruthenium Complex in Tumor Diagnosis and Therapy Glutathione binding to dirhodium tetraacetate: a spectroscopic, mass spectral and computational study of an anti tumour compound Metallomics (RSC Publishing) DOI:10.1039 C7MT00040E
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



